Adtalem Global Education Inc.
ATGE
Rangering i aksjer
#4051
Adtalem Global Education Inc. is a global enterprise dedicated to delivering... Adtalem Global Education Inc. is a global enterprise dedicated to delivering comprehensive workforce and educational solutions. Established in 1987 and headquartered in Chicago, Illinois, the company was formerly known as DeVry Education Group Inc. until its name change in May 2017. The organization operates through three distinct segments: 1. Chamberlain: This division offers both academic degree programs and specialized non-degree coursework within the nursing and health professions postsecondary education sector, primarily facilitated by Chamberlain University. 2. Walden: Focused on online learning, the Walden segment provides a wide array of qualifications, from certificates and bachelor's degrees to master's and doctoral programs. These offerings, delivered via Walden University, span numerous fields including nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. 3. Medical and Veterinary: This segment is committed to postsecondary education in medical and veterinary sciences, furnishing students with both degree and non-degree program options. Its institutions include the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Aksjekurs
$113.13
Sist synkronisert: 2026-04-13
Markedsverdi
$4.04B
Endring (1 dag)
0.97%
Endring (1 år)
-26.10%
Land
US
Handel Adtalem Global Education Inc. (ATGE)
Kategori
Consumer Defensive
P/E-forhold for Adtalem Global Education Inc. (ATGE)
P/E-forhold per October 2026 TTM: 15.04
Ifølge Adtalem Global Education Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 15.04. Ved slutten av 2024 hadde selskapet en P/E på 19.38.
P/E-forholdshistorikk for Adtalem Global Education Inc. fra 2000 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 15.04 | -24.42% |
| 2025 | 19.90 | 2.68% |
| 2024 | 19.38 | 17.68% |
| 2023 | 16.47 | 194.31% |
| 2022 | 5.60 | -78.57% |
| 2021 | 26.12 | 280.58% |
| 2020 | 6.86 | -64.58% |
| 2019 | 19.38 | -77.87% |
| 2018 | 87.55 | 345.22% |
| 2017 | 19.66 | -105.45% |
| 2016 | -360.83 | -2,711.77% |
| 2015 | 13.82 | -31.80% |
| 2014 | 20.26 | 6.35% |
| 2013 | 19.05 | 29.61% |
| 2012 | 14.70 | 17.56% |
| 2011 | 12.50 | -6.64% |
| 2010 | 13.39 | -37.92% |
| 2009 | 21.57 | -29.16% |
| 2008 | 30.45 | -3.84% |
| 2007 | 31.66 | -12.09% |
| 2006 | 36.02 | -25.42% |
| 2005 | 48.30 | 30.60% |
| 2004 | 36.98 | 38.13% |
| 2003 | 26.77 | 16.29% |
| 2002 | 23.02 | -47.19% |
| 2001 | 43.59 | 13.81% |
| 2000 | 38.30 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| - | - |
CN
|
|
| 2.53 | -83.20% |
CN
|
|
| 17.77 | 18.15% |
US
|
|
| 9.46 | -37.08% |
US
|
|
| 19.26 | 28.04% |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.